Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.com
Google Alert - NSCLC AND EMA AND Europe
Get the latest updates from Google Alert - NSCLC AND EMA AND Europe directly as they happen.
Follow now 143 followers
Latest posts
Last updated about 1 month ago
Europe Oncology Market Size, Share & Trends, 2033
about 1 month ago
The European Medicines Agency (EMA) has also expedited approvals for breakthrough oncology...
FDA approves diagnostic tool for MET-targeted lung cancer therapy - Pharmafile
about 1 month ago
Moleculin Biotech has received approval from the European Medicines Agency (EMA) to...
Opdivo Perioperative Regimen Approved in Europe for PD-L1-Positive NSCLC Patients
about 2 months ago
non-small cell lung cancer · PD-L1 Biomarkers · Europe. We recommend. EMA's...
Rozanolixizumab for gMG Approved in Japan for Self-Administration
about 2 months ago
https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3 ... lung cancer (NSCLC) with high c-met protein overexpression. AbbVie ...
Reirradiation: 'Attractive' Option in Recurrent NSCLC - Medscape
about 2 months ago
Why Lung Cancer Screening Is Not for Everyone · Two Lung Cancer...
CT Follow-up Strategy Optimises Lung Cancer Screening - Medscape
about 2 months ago
Non-Small Cell Lung Cancer (NSCLC) Imaging · Survivorship ... Two Lung Cancer...
April 2025 — CDMO Opportunities And Threats Report - Bioprocess Online
about 2 months ago
... (NSCLC) at high risk of recurrence and no epidermal ... EMA...
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
about 2 months ago
Company received approval from European Medicines Agency (EMA) for CLN-978; Phase 1...
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
about 2 months ago
... NSCLC treatment, with results to be presented at ASCO 2025. The...
Top 20 Lung Cancer Drugs Market Analysis and Segment Forecasts to 2030
about 2 months ago
... EU, and select Asia-Pacific regions. Agencies like the U.S. FDA and...
European regulators to review Valneva shot; Jazz's stock dips on subpar first-quarter revenue
about 2 months ago
Plus, news about NewAmsterdam, C4 Therapeutics, Vivo Capital, and Arcus Biosciences: EMA...
Johnson & Johnson submits application for subcutaneous Rybrevant dosing - PharmaTimes
about 2 months ago
Janssen-Cilag International NV, a Johnson & Johnson company, has submitted an application...